Recent posts
-
What is a Gleason Score
Pathologists review biopsy tissue and assign it a Gleason grade based on the appearance of the cells. If cancer is […]
-
Understanding PSA
-
Prostate cancer on the rise in 2022
-
Genetic insights for more actionable and personalized prostate cancer
-
Prolaris® is advancing prostate cancer care at ASCO GU
-
Prolaris® is Helping Urologists Reimagine Prostate Cancer Care
-
New Study Proves that Prolaris can Determine which Patients Can Safely Avoid ADT
-
2021 Prostate Cancer Statistics
-
New Data Validating the Prolaris® Test to Guide Treatment for Prostate Cancer
-
The Importance of Genetic Testing for Prostate Cancer P2
-
The Importance of Genetic Testing for Prostate Cancer P1
-
1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation
-
The Prolaris Test Gave Me Information I Needed
-
New Treatment Options Available
-
Genetic Testing Changed My Life
-
Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer